# Triveni Bio

**Canonical:** https://apis.io/providers/triveni-bio/  
**Website:** https://triveni.bio/  
**APIs profiled:** 0

Triveni Bio is a clinical-stage biotechnology company developing first-in-class antibody therapeutics for immunological and inflammatory (I&I) disorders, built on a genetics-informed approach to target discovery combined with advanced antibody engineering. Its lead program TRIV-509 is a dual-specific monoclonal antibody against kallikreins 5 and 7 (KLK5/7) for moderate-to-severe atopic dermatitis, addressing barrier dysfunction, inflammation and itch; TRIV-573 is a half-life-extended, second-generation bispecific that pairs the KLK5/7 mechanism with anti-interleukin-13 (IL-13) and entered Phase 1 in 2026. The pipeline also includes an antibody inhibitor of trypsin 1 and 2 for hereditary pancreatitis driven by PRSS1 mutations. The company launched with a $92M Series A, raised a $115M Series B, and closed a $65M Series C in June 2026, and was named a Fierce 15 biotech of 2025. Triveni Bio is a therapeutics developer, not a software vendor: it publishes no public API, developer portal, SDK or machine-readable specification.

## Kin Score — 11.5 / 100 (minimal)

Scored 2026-08-17 under rubric 0.11.0. Trend: flat (+0.0 from 11.5).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.2 |
| Commercial Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Security (1)

- **Triveni Bio Domain Security** — TLSv1.3

## Tags

Company, Biotechnology, Life Sciences, Pharmaceuticals, Therapeutics, Antibodies, Immunology, Drug Development, Clinical Trials, Healthcare

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/triveni-bio/). Scores are computed from the provider's own public artifacts under a published rubric.